Trials / Conditions / Lobular Breast Carcinoma

Lobular Breast Carcinoma

13 registered clinical trials studyying Lobular Breast Carcinoma — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	18F FES-PET/MRI for Tailoring Treatment of Luminal a and Lobular Breast Cancer NCT05982496	Università Vita-Salute San Raffaele	N/A
Recruiting	A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer NCT06557148	Memorial Sloan Kettering Cancer Center	—
Recruiting	Biomarkers to Detect Endocrine Therapy Resistance NCT06067503	University of Wisconsin, Madison	Phase 2
Recruiting	Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry) NCT05964504	University of California, San Francisco	—
Active Not Recruiting	Initial Staging of Lobular Breast Carcinoma: Head to Head Comparison of 68Ga-FAPI-46 and 18F-FDG PET/CT NCT05931302	Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer	N/A
Recruiting	A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue NCT05837767	Memorial Sloan Kettering Cancer Center	N/A
Active Not Recruiting	LobularCard Trial: Searching for Novel Germline Mutations in Lobular Breast Cancer Patients NCT05410951	European Institute of Oncology	—
Completed	Crizotinib in Lobular Breast, Diffuse Gastric and Triple Negative Lobular Breast Cancer or CDH1-mutated Solid NCT03620643	Royal Marsden NHS Foundation Trust	Phase 2
Completed	Living Well After Breast Surgery NCT03834532	University of Texas at Austin	N/A
Completed	CDH1 Germline Mutations in Lobular Breast Cancer NCT04206891	European Institute of Oncology	—
Active Not Recruiting	Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa B NCT03414970	Alliance for Clinical Trials in Oncology	Phase 3
Completed	Broccoli Sprout Extract in Treating Patients With Breast Cancer NCT01753908	Roswell Park Cancer Institute	EARLY_Phase 1
Unknown	Monitoring Response After The First Chemotherapy Cycle After Neoadjuvant Breast Cancer Therapy NCT01038258	Auxilio Mutuo Cancer Center	N/A